An observational study in Stillbirth and Placental Insufficiency, sponsored by Oregon Health and Science University. Recruiting at 1 site in United States. Open to female participants aged 15 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-12-17.
Sponsored by Oregon Health and Science University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Stillbirth with a site in United States — 11 open to participants now, 11 under way, 1 of them phase 3. Stillbirth · United States.
Among the 22 studies in Stillbirth with a site in United States, this one is one of 4 that started in 2025, is one of 8 observational ones, reaches primary completion later than 8 of the 10 other live ones, and was the 19th registered.
121 studies on the registry are indexed under Stillbirth; 34 are open to participants now.
Browse Stillbirth studies →11 of the 22 studies in Stillbirth with a site in United States are open now. Recruiting first, the newest first:
Kenneth Moise MD · Sites in United States
Ages 18–45 · Women only
Oregon Research Behavioral Intervention Strategies, Inc. · Sites in United States
Ages 15+ · Healthy volunteers
The George Washington University Biostatistics Center · Sites in United States
Ages 14+ · Women only · Healthy volunteers
Carilion Clinic · Sites in United States
Ages 18–45 · Women only
Tufts Medical Center · Sites in United States
Ages 12–50 · Women only · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 24 Stillbirth studies recruiting now, 10 (42%) set no upper age limit and 14 (58%) stop at 75 or younger; 10 take children under 18; 10 take healthy volunteers.
This study: 15 Years to 50 Years · female · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 3 · Phase 4 1
First in 2008; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 640 is above the median of 480 across 55 observational studies indexed under Stillbirth.
Median enrollment 61 across the 14 interventional studies, 369 across the 8 observational. Of the 10 that completed or were terminated, 6 (60%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 22 have an industry lead sponsor. The 10 most frequent:
Oregon Health and Science University is the lead sponsor of 696 studies on the registry; 131 are open to participants now.
Of its 52 completed or terminated interventional studies of FDA-regulated products, 39 (75%) have results posted.
Oregon Health and Science University has 1 study filed under Stillbirth — fewer than ten, so there is no comparison to draw.
4 of the studies in Stillbirth with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05472597RTI InternationalContinuation of the nuMoM2b Heart Health Study | 2027-01 |
| NCT06004674Endeavor HealthUsing Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project | 2027-03 |
| NCT07011940Oregon Research Behavioral Intervention Strategies, Inc.Walk With Me (WWM) for Perinatal Grief | 2027-08-01 |
| NCT07626112Kenneth Moise MDFeasibility Trial of the Womb Watch Smartphone App To Assess Fetal Movements | 2027-09-30 |
Add all 4 to your calendar (.ics) → With an account.
Among the 22 studies in Stillbirth with a site in United States, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This is a prospective observational study with the goal of developing and assessing a predictive model of placental insufficiency.
Pregnant study participants will be recruited and monitored throughout pregnancy with ultrasound and blood draws, and delivery and neonatal data up to 28 days following birth. This data will be used to develop a model to predict placental insufficiency.
Pregnant people age 15 and older, parous and nulliparous, without known major fetal anatomic or genetic abnormalities. Participants must be pregnant with a singleton living gestation, less than 22 weeks' gestation at enrollment, and planning to deliver at Oregon Health \& Science University.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Pregnant people age 15 and older, without known major fetal anatomic or genetic abnormalities, singleton gestation will be monitored via ultrasound and blood tests throughout pregnancy. Delivery data and neonatal outcomes will be collected. Data will be used to develop a predictive model of placental insufficiency.
Other: Data Collection Throughout Pregnancy and Delivery
Participants will receive monitoring by ultrasound and blood tests at three time points during pregnancy, and delivery and neonatal data will be collected.
Number of participants with placental insufficiency composite
The composite is made of the following: stillbirth and neonatal death, severe forms of hypertensive disease, placental abruption, birthweight below the 3rd percentile, umbilical cord arterial pH\<7, and/or placental primary indication for delivery (FGR, oligohydramnios, abnormal fetal testing)
Time frame: At time of delivery to 28 days following delivery
Started Sep 2025 (actual). Primary completion is estimated for Jun 2029, 45 months after the start.
Of 30 observational studies under Stillbirth, half reached primary completion within 91 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 122. This study's planned 45 months is below that.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Oregon Health and Science University →